Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 2 (February)

1. Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation.
   Am J Psychiatry, 164(2): 309-17. [Abstract] [Full-text]
2. Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33.
   Am J Psychiatry, 164(2): 236-47. [Abstract] [Full-text]
3. Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia.
   Eur Psychiatry, 22(1): 39-43. [Abstract] [Full-text]
4. Cognitive Functioning and Instrumental Activities of Daily Living in Late-Life Bipolar Disorder.
   Am J Geriatr Psychiatry, 15(2): 174-179. [Abstract] [Full-text]
5. Positive association between SIAT8B and schizophrenia in the Chinese Han population.
   Schizophr Res, 90(1): 108-14. [Abstract] [Full-text]
6. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder.
   Schizophr Res, 90(1): 258-65. [Abstract] [Full-text]
7. Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: Implications for oligodendrocyte viability.
   Neurochem Int, 50(3): 461-90. [Abstract] [Full-text]
8. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.
   Arch Gen Psychiatry, 64(2): 201-8. [Abstract] [Full-text]
9. Neural and genetic correlates of antidepressant response to sleep deprivation: a functional magnetic resonance imaging study of moral valence decision in bipolar depression.
   Arch Gen Psychiatry, 64(2): 179-87. [Abstract] [Full-text]
10. A mixed state core for melancholia: an exploration in history, art and clinical science.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
11. The incidence and prevalence of manic-melancholic syndromes in North West Wales: 1875-2005.
    Acta Psychiatr Scand Suppl. [Abstract] [Full-text]
12. Differential effect of lithium on the circadian oscillator in young and old hamsters.
    Biochem Biophys Res Commun, 354(3): 752-6. [Abstract] [Full-text]
13. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    J Child Adolesc Psychiatr Nurs, 20(1): 40-58. [Abstract] [Full-text]
14. ER stress and diseases.
    FEBS J, 274(3): 630-58. [Abstract] [Full-text]
15. High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(2): 370-2. [Abstract] [Full-text]
16. Late onset bipolar disorder associated with white matter hyperintensities: a pathophysiological hypothesis.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(2): 551-6. [Abstract] [Full-text]
17. Association between obsessive-compulsive disorder and a variable number of tandem repeats polymorphism in intron 2 of the serotonin transporter gene.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(2): 416-20. [Abstract] [Full-text]
18. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(2): 574-7. [Abstract] [Full-text]
19. The interface between borderline personality disorder and bipolar spectrum disorders.
    Compr Psychiatry, 48(2): 145-54. [Abstract] [Full-text]
20. Anatomical measurements of the orbitofrontal cortex in child and adolescent patients with bipolar disorder.
    Neurosci Lett, 413(3): 183-6. [Abstract] [Full-text]
21. Orally disintegrating olanzapine for the treatment of a manic patient with esophageal stricture plus chronic pharyngitis.
    Prog Neuropsychopharmacol Biol Psychiatry, 31(2): 541-2. [Abstract] [Full-text]
22. Enhanced relapse prevention for bipolar disorder--ERP trial. A cluster randomised controlled trial to assess the feasibility of training care coordinators to offer enhanced relapse prevention for bipolar disorder.
    BMC Psychiatry, 7: 6. [Abstract] [Full-text]
23. Serum S100B and antioxidant enzymes in bipolar patients.
    J Psychiatr Res, 41(6): 523-9. [Abstract] [Full-text]
24. A growth in bipolar disorder?
    Acta Psychiatr Scand, 115(3): 246-50; discussion 250. [Abstract] [Full-text]
25. Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.
    Biol Psychiatry, 61(5): 640-52. [Abstract] [Full-text]
26. Attempted suicide in bipolar disorder pedigrees: evidence for linkage to 2p12.
    Biol Psychiatry, 61(5): 725-7. [Abstract] [Full-text]
27. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
    Mol Pharmacol, 71(3): 884-92. [Abstract] [Full-text]
28. Different behaviors and different strains: Potential new ways to model bipolar disorder.
    Neurosci Biobehav Rev. [Abstract] [Full-text]
29. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 78(3): 248-52. [Abstract] [Full-text]
30. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
    Expert Opin Pharmacother, 8(4): 457-66. [Abstract] [Full-text]
31. Cognitive flexibility in phenotypes of pediatric bipolar disorder.
    J Am Acad Child Adolesc Psychiatry, 46(3): 341-55. [Abstract] [Full-text]
32. Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania.
    J Am Acad Child Adolesc Psychiatry, 46(3): 356-61. [Abstract] [Full-text]
33. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies.
    J Am Acad Child Adolesc Psychiatry, 46(3): 309-22. [Abstract] [Full-text]
34. Early recognition of bipolar disorder.
    Eur Psychiatry, 22(2): 92-8. [Abstract] [Full-text]
35. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium.
    J Circadian Rhythms, 5: 3. [Abstract] [Full-text]
36. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder.
    J Affect Disord, 99(1): 221-9. [Abstract] [Full-text]
37. Carbon dioxide provocation of anxiety and respiratory response in bipolar disorder.
    J Affect Disord, 99(1): 45-9. [Abstract] [Full-text]
38. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.
    J Affect Disord, 99(1): 19-25. [Abstract] [Full-text]
39. Dimensions underlying outcome criteria in bipolar I disorder.
    J Affect Disord, 99(1): 1-7. [Abstract] [Full-text]
40. A strategy for identifying phenotypic subtypes: concordance of symptom dimensions between sibling pairs who met screening criteria for a genetic linkage study of childhood-onset bipolar disorder using the Child Bipolar Questionnaire.
    J Affect Disord, 99(1): 27-36. [Abstract] [Full-text]
41. Childhood antecedent disorders to bipolar disorder in adults: a controlled study.
    J Affect Disord, 99(1): 51-7. [Abstract] [Full-text]
42. Coeliac disease and risk of mood disorders--a general population-based cohort study.
    J Affect Disord, 99(1): 117-26. [Abstract] [Full-text]
43. Life stress and the course of early-onset bipolar disorder.
    J Affect Disord, 99(1): 37-44. [Abstract] [Full-text]
44. Association between illicit drug and alcohol use and first manic episode.
    Pharmacol Biochem Behav, 86(2): 395-400. [Abstract] [Full-text]
45. Malic enzyme 2 and susceptibility to psychosis and mania.
    Psychiatry Res, 150(1): 1-11. [Abstract] [Full-text]
46. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature.
    J Gastroenterol, 42(1): 39-48. [Abstract] [Full-text]
47. Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.
    J Affect Disord, 99(1): 247-51. [Abstract] [Full-text]
48. Effects of chronic prednisone therapy on mood and memory.
    J Affect Disord, 99(1): 279-83. [Abstract] [Full-text]
49. The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal.
    J Affect Disord, 99(1): 91-9. [Abstract] [Full-text]
50. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
    J Affect Disord, 99(1): 9-17. [Abstract] [Full-text]
51. Changes in plasma cholesterol in mood disorder patients: does treatment make a difference?
    J Affect Disord, 99(1): 273-8. [Abstract] [Full-text]
52. A Goal-Striving Life Event and the Onset of Hypomanic and Depressive Episodes and Symptoms: Perspective From the Behavioral Approach System (BAS) Dysregulation Theory.
    J Abnorm Psychol, 116(1): 105-15. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.